Long-term risk of HCC in a DAA-treated national hepatitis C cohort, and a proposed risk score

This is the authors' abstract. We don't add key points for this paper.

The risk of hepatocellular carcinoma (HCC) remains elevated in cirrhotic hepatitis C patients with sustained virological response (SVR) after DAA treatment. We assessed long-term HCC risk stratified by pretreatment liver stiffness measurement (LSM) and developed a risk score algorithm.